相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants A Comparative Modeling Analysis
Kathryn P. Lowry et al.
JAMA ONCOLOGY (2022)
Rapid Genetic Testing forBRCA1andBRCA2Mutations at the Time of Breast Cancer Diagnosis: An Observational Study
Kelly A. Metcalfe et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
A Population-Based Study of Genes Previously Implicated in Breast Cancer
Chunling Hu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women
Leila Dorling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Cost-Effectiveness of Targeted Genetic Testing for Breast and Ovarian Cancer: A Systematic Review
Andreas Koldehoff et al.
VALUE IN HEALTH (2021)
Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result
Kelly A. Metcalfe et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study
Dhivya Chandrasekaran et al.
CANCERS (2021)
Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG)
Tuya Pal et al.
GENETICS IN MEDICINE (2020)
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
Xin Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients
Allison W. Kurian et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Consensus Guidelines on Genetic Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons
Eric R. Manahan et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
Li Sun et al.
JAMA ONCOLOGY (2019)
Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
Peter D. Beitsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The association of multimorbidity with healthcare expenditure among the elderly patients in Beijing, China
He Chen et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2018)
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Claudia Allemani et al.
LANCET (2018)
Cost-effectiveness analyses of genetic and genomic diagnostic tests
Katherine Payne et al.
NATURE REVIEWS GENETICS (2018)
Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel data
C. van Marcke et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing
Jacqueline Mersch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer
Christopher P. Childers et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
Jie Sun et al.
CLINICAL CANCER RESEARCH (2017)
Adherence to Needed Adjuvant Therapy Could Decrease Recurrence Rates for Rural Patients With Early Breast Cancer
Qijia Xuan et al.
CLINICAL BREAST CANCER (2016)
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine
Gillian D. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
B. A. M. Heemskerk-Gerritsen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
Xinglei Chai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Douglas F. Easton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
Xinglei Chai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
B. A. M. Heemskerk-Gerritsen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Breast-Cancer Risk in Families with Mutations in PALB2
A. C. Antoniou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Breast cancer in women at high risk: The role of rapid genetic testing for BRCA1 and-2 mutations and the consequences for treatment strategies
Anne Brecht Francken et al.
BREAST (2013)
Long-Term Mortality Associated With Oophorectomy Compared With Ovarian Conservation in the Nurses' Health Study
William H. Parker et al.
OBSTETRICS AND GYNECOLOGY (2013)
A Nation-Wide Multicenter Retrospective Study of the Epidemiological, Pathological and Clinical Characteristics of Breast Cancer In Situ in Chinese Women in 1999-2008
Yanan Kong et al.
PLOS ONE (2013)
Genetic services and testing in China
Xinliang Zhao et al.
JOURNAL OF COMMUNITY GENETICS (2013)
Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis
R. Manchanda et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2012)
A Nation-Wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in china
Jing Li et al.
BMC CANCER (2011)
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
Susan M. Domchek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Uptake of Risk-Reducing Surgery in Unaffected Women at High Risk of Breast and Ovarian Cancer Is Risk, Age, and Time Dependent
D. Gareth R. Evans et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
Timothy R. Rebbeck et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Increased cardiovascular mortality after early bilateral oophorectomy
Cathleen M. Rivera et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
Kelly A. Metcalfe et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Validation of health economic models: The example of EVITA
T Hammerschmidt et al.
VALUE IN HEALTH (2003)
分享论文
